Aprea Therapeutics Inc (APRE) — Strategic Asset Allocation Index
Aprea Therapeutics Inc (APRE) has a Strategic Asset Allocation Index of 0.0% as of June 2023. Strategic assets (PP&E of $1.69K plus long-term investments of $-) total $1.69K, measured against net assets of $23.42 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Aprea Therapeutics Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Aprea Therapeutics Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 0.0%, representing strategic assets of $1.69K against net assets of $23.42 Million USD. Explore Aprea Therapeutics Inc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Aprea Therapeutics Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Aprea Therapeutics Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Aprea Therapeutics Inc market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $2.32K | $2.32K | $- | $25.64 Million | ▼ -0.4 pp |
| 2021 | 0.4% | $209.68K | $209.68K | $- | $49.51 Million | ▼ 0.0 pp |
| 2020 | 0.5% | $359.13K | $359.13K | $- | $77.40 Million | ▲ +0.0 pp |
| 2019 | 0.5% | $563.03K | $563.03K | $- | $124.24 Million | — |